Results 141 to 150 of about 2,367,876 (222)

Vibecotamab for measurable residual disease in acute myeloid leukemia and for myelodysplastic syndromes and chronic myelomonocytic leukemia after hypomethylating agent failure: a phase II study. [PDF]

open access: yesJ Hematol Oncol
Short NJ   +20 more
europepmc   +1 more source

Common ancestral origin of indeterminate dendritic cell tumor and chronic myelomonocytic leukemia in clonal hematopoiesis. [PDF]

open access: yesHaematologica
Sato A   +10 more
europepmc   +1 more source

ALK-positive histiocytosis and a clonally related chronic myelomonocytic leukemia. [PDF]

open access: yesHaematologica
Breimer GE   +9 more
europepmc   +1 more source

Venetoclax-Based Regimens in Chronic Myelomonocytic Leukemia: A Systematic Review and Meta-Analysis.

open access: yesActa Haematol
Abdulgayoom M   +7 more
europepmc   +1 more source

Landscape and clinicopathologic features of RAS pathway mutations in chronic myelomonocytic leukemia. [PDF]

open access: yesBlood Adv
Montalban-Bravo G   +31 more
europepmc   +1 more source

IgA vasculitis associated with chronic myelomonocytic leukemia. [PDF]

open access: yesBMC Rheumatol
Rouvière B   +6 more
europepmc   +1 more source

Concomitant plasma cell myeloma and chronic myelomonocytic leukemia in elderly: diagnostic complexity, therapeutic challenges - case report and literature review. [PDF]

open access: yesAnn Med Surg (Lond)
Rohita DK   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy